Article
Sofosbuvir/velpatasvir/voxilaprevir plus ribavirin for chronic hepatitis C patients with direct acting antiviral failures: Implications for viral elimination in Taiwan.
Journal of the Formosan Medical Association = Taiwan yi zhi - 1 Dec 2020
Liu Chen-Hua, Su Tung-Hung, Liu Chun-Jen, Chen Pei-Jer, Chen Ding-Shinn, Kao Jia-Horng
Abstract excerpt
Despite the excellent antiviral effects of direct acting antivirals (DAAs) for hepatitis C virus (HCV) infection with subsequent decrease of morbidity and mortality, a small proportion (5%) of the treated patients do not respond to first-line DAAs and have persistent viremia. Rescue therapy for patients with DAA failures is thus mandatory from both clinical and public health perspectives....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.